ALCYONE THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About ALCYONE THERAPEUTICS INC

Biogen is a biotechnology company focused on developing innovative treatments for rare and complex diseases, including Spinal Muscular Atrophy (SMA). The company has received FDA approval for the first therapy to treat SMA and continues to advance research in neuromuscular indications.

Development of innovative therapies for rare diseasesCollaboration with pharmaceutical partners for new therapeutic optionsClinical trials and early access programs for investigational therapiesResearch and development in antisense oligonucleotide (ASO) candidates

Is this your company?

Claim ALCYONE THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim ALCYONE THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.